Ensuring the Quality of Stem Cell-Derived In Vitro Models for Toxicity Testing

Area of Science:

• Toxicology
• Stem Cell Biology
• In Vitro Assays

Background:

• Reliable in vitro toxicology data is essential for new drug and consumer product safety.
• Human pluripotent stem cell (hPSC) lines offer promising models for in vitro toxicology but require stringent quality control.
• Current challenges include standardizing hPSC-based assays for regulatory and commercial acceptance.

Purpose of the Study:

• To outline scientific and ethical criteria for developing toxicology assays using hPSC lines.
• To identify key considerations for regulatory, laboratory safety, and commercial acceptance of hPSC-based assays.
• To guide the development of hPSC assays for relevant drug toxicology applications.

Main Methods:

• Review of expert opinion from the SEURAT-1 cluster (European Commission/Cosmetics Europe).
• Consensus building with international groups, including the International Stem Cell Banking Initiative.
• Synthesis of up-to-date best practices in hPSC line quality control and utilization.

Main Results:

• Key scientific and ethical criteria for hPSC assay development are detailed.
• Considerations for regulatory, safety, and commercial viability of hPSC assays are identified.
• Best practices for quality control of hPSC lines in in vitro toxicology are summarized.

Conclusions:

• Standardized quality control of hPSC lines is paramount for reproducible and accurate in vitro toxicology.
• Adherence to outlined criteria will facilitate the regulatory acceptance and application of hPSC-based assays.
• This guidance provides a framework for developing robust and reliable hPSC-derived toxicology testing methods.